CLINDAMYCIN hydrochloride, eq. 300mg base, caps.
STD
DORACLIN3C-
Valid Article
Account code:
60000
HS Code:
300420
Last Updated on:
07/11/2024, 18:56:02
Former
Code(s):
-X
6.2.1 - Access group antibiotics
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
J01FF01
Anatomical Therapeutic Chemical Classification according to WHOCC
OC subscriptions: included in supply or field order tools (e.g. UniField)
|
|
SC subscriptions: included in supply or field tools
|
|
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
|
|
CLINDAMYCIN
Therapeutic Action
Lincosamide antibacterial
Indications
Severe staphylococcal and/or streptococcal infections
Completion treatment following parental therapy with clindamycin
Instructions for use
The 150 mg dosage is intended for paediatric use.
Storage
Below 25ºC -Protect from sunlight
![[KMEDMHIM23A] (mod ICU) ORAL MEDICINES 2021](/web/image/product.template/574423/image_256/%5BKMEDMHIM23A%5D%20%28mod%20ICU%29%20ORAL%20MEDICINES%202021?unique=dcc4b7f)
![[KMEDMHWM33A] (mod ward) ORAL MEDICINES 2021](/web/image/product.template/574422/image_256/%5BKMEDMHWM33A%5D%20%28mod%20ward%29%20ORAL%20MEDICINES%202021?unique=904b96e)
![[DINJCLIN3A-] CLINDAMYCIN phosphate, eq. 150mg base/ml, 2ml, amp.](/web/image/product.template/571936/image_256/%5BDINJCLIN3A-%5D%20CLINDAMYCIN%20phosphate%2C%20eq.%20150mg%20base-ml%2C%202ml%2C%20amp.?unique=301546e)